
Dr. Luis Martinez-Piñeiro (FEBU) graduated in Medicine from the Universidad Autonoma de Madrid, Spain, in 1985, and obtained his M.D. from the Universidad Autonoma de Madrid, Spain, in 1991. He is currently the Chief of the Urology Service at Hospital Universitario La Paz, Madrid, Spain. Previously he was head of the urology unit at Hospital Universitario Infanta Sofia between December 2007 and November 2016 and F.E.A. at Hospital Universitario La Paz, Madrid between 1991 and 2007. He was a member of the board of directors (EAU Board) of the European Association of Urology between 2004 and 2016. In 2006 he was accredited as a professor by the Spanish National Accreditation Agency (ANECA), and is currently the National Coordinator of the CUETO Group. Dr. Martínez-Piñeiro is currently an active member of the Spanish Association of Urology, the European Association of Urology, the American Urological Association, the International Urological Society, the Spanish Association of Oncological Research (ASEICA) and an honorary member of the Argentine Association of Urology. Dr. Martínez-Piñeiro has published more than 170 articles in Spanish and English, and is Associate Editor of the journal "Archivos Españoles de Urología" and member of the Editorial Board of the journal European Urology.
Selected publications from PubMed
Recommendations for the prevention and treatment of adverse effects of intravesical BCG.
Alvarez-Ossorio JL, Alvarez-Maestro M, Cozar-Olmo JM, Espinosa-Bosch M, Florido-Pérez I, Guerrero-Ramos F, Martinez-Piñeiro L, Olivares-Corral J, Rodriguez-Quecedo M, Rodriguez-Faba O
Actas Urol Esp (Engl Ed). 2026 Jul 27;:502005 doi: 10.1016/j.acuroe.2026.502005.
Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study.
Rubio-Briones J, Guerrero Ramos F, Mercadé Sánchez A, Bezana Abadía I, Martín Rodríguez R, Alcaraz A, Miqueleiz Legaz M, Lozano F, Arrabal Martín M, Luis Cardo A, Gonzalo Rodríguez V, Caño Velasco J, Serrano Liesa M, Ferreiro Pareja C, Espílez Ortiz R, González-Valcárcel de Torres I, Sánchez Zalabardo D, Guijarro A, Mengual L, Borque-Fernando A, Esteban Escaño LM, Palou Redorta J, Witjes F, Martínez Piñeiro L
BJU Int. 2026 Jul;138(1):75-84 doi: 10.1111/bju.70230.
External validation of the Uromonitor®-version 2 urine test as a biomarker for optimisation of non-muscle-invasive bladder cancer management.
Rubio-Briones J, Guerrero Ramos F, Mercadé Sánchez A, Bezana Abadía I, Rodríguez RM, Alcaraz A, Miqueleiz Legaz M, Lozano F, Arrabal Martín M, Luis Cardo A, Gonzalo Rodríguez V, Caño Velasco J, Serrano Liesa M, Ferreiro Pareja C, Espílez Ortiz R, de González-Valcárcel de Torres I, Sánchez Zalabardo D, Esquinas C, Mengual L, Borque-Fernando A, Esteban Escaño LM, Palou Redorta J, Witjes F, Martínez Piñeiro L
BJU Int. 2026 Jan;137(1):216-224 doi: 10.1111/bju.70010.
International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity.
Paciotti M, Diana P, Gallioli A, De Groote R, Farinha R, Ficarra V, Gaston R, Gontero P, Hurle R, Martínez-Piñeiro L, Minervini A, Pansadoro V, Van Cleynenbreugel B, Wiklund P, Casale P, Lughezzani G, Uleri A, Mottrie A, Palou J, Gallagher AG, Breda A, Buffi N
BJU Int. 2024 Dec;134(6):932-938 doi: 10.1111/bju.16433.
Randomized clinical trial on the use of IMAGE1 S LIGHT (SPIES) vs. white light in the prevention of recurrence during transurethral resection of bladder tumors: Analysis after 12-month follow-up.
Trelles Guzmán CR, Linares Espinós E, Ríos González E, Alonso Dorrego JM, Aguilera Bazán A, Jiménez Romero ME, Martínez-Piñeiro L
Actas Urol Esp (Engl Ed). 2024 Sep;48(7):512-520 doi: 10.1016/j.acuroe.2023.12.005.
Help your network discover Dr. Luis Martinez Piñeiro's clinical expertise.